• Health & Medicine
• Science & Technology

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference. Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference.

19 September 2021

• For Researchers
• Science & Technology

How cancer hijacks cell death: a new view of metastasis

Professor Jody Rosenblatt tells us why dysregulated cell death could have an impact not only on metastasis, but also therapy resistance. Professor Jody Rosenblatt tells us why dysregulated cell death could have an impact not only on metastasis, but also therapy resistance.

17 September 2021

• For Researchers

Kinder and more effective - why childhood cancers need specific treatments

Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments. Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments.

3 September 2021

• Policy & Insight
• Health & Medicine

Should alcohol marketing be dropped from televised sport?

During the 2019 Six Nations,122.4 billion Guinness-related branded impressions were delivered to the UK population who watched the coverage. During the 2019 Six Nations,122.4 billion Guinness-related branded impressions were delivered to the UK population who watched the coverage.

27 August 2021

• Health & Medicine

New drug combo for advanced breast cancer approved for NHS in England

People with a certain type of advanced breast cancer will now have routine access to a new treatment option in England. People with a certain type of advanced breast cancer will now have routine access to a new treatment option in England.

13 August 2021

• For Researchers
• Science & Technology

Embedding research integrity at the core of our science

Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity

28 July 2021

• Science & Technology

Scientists developing urine and blood tests to detect brain tumours

Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma. Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma.

23 July 2021

• For Researchers

A vision for the next decade of UK life sciences

What could the government’s Life Sciences Vision mean for cancer research? What could the government’s Life Sciences Vision mean for cancer research?

21 July 2021

• Health & Medicine

One in 5 less likely to take part in cancer screening

A Cardiff University-led UK-wide survey has found that more than 1 in 5 people are less likely to take part in cancer screening than before the pandemic. A Cardiff University-led UK-wide survey has found that more than 1 in 5 people are less likely to take part in cancer screening than before the pandemic.

16 July 2021

• Health & Medicine

Blood test could tailor treatment after surgery

A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible. A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible.

14 July 2021

• For Researchers

Coming together for Zynlonta

How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma. How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma.

2 July 2021

• Science & Technology

Urine test for bladder cancer being developed

The University of Birmingham has partnered with Nonacus, a company that develops non-invasive genetic testing devices, to produce a urine test for bladder cancer that could spare thousands of people invasive procedures. The University of Birmingham has partnered with Nonacus, a company that develops non-invasive genetic testing devices, to produce a urine test for bladder cancer that could spare thousands of people invasive procedures.

2 July 2021